United States Polymyositis Market Size & Outlook, 2026-2034


United States Polymyositis Market Insights

  • Based on Reed Intelligence findings, the United States Polymyositis Market reached USD 289.49 Million in 2025 and is estimated to attain USD 525.7 Million by 2034.
  • From 2026 to 2034, the United States market is expected to grow at a steady CAGR of 6.87%.
  • Within the Treatment Type category, Corticosteroids dominated in 2025 in terms of market size contribution.
  • Over the forecast period, Immunosuppressants is forecasted to deliver the fastest growth, positioning it as the most lucrative Treatment Type segment.

Other Key Findings


  • United States accounted for 22.62% of the global Polymyositis Market size in 2025.
  • By 2034, United States is expected to remain the top global market in terms of size.
  • Within North America, United States is forecasted to dominate the regional Polymyositis Market size by 2034.
  • Canada will be the fastest-growing market in North America, projected to achieve USD 197.17 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 289.49 Million
Market Size In 2034 USD 525.7 Million
Largest segment Corticosteroids
Units Revenue in USD Million
CAGR 6.87% (2026-2034)
Segmnetation Covered
Treatment Type
  1. Corticosteroids
  2. Immunosuppressants
  3. Biologics
  4. Others
Diagnosis Method
  1. Blood Tests
  2. Imaging Techniques
  3. Muscle Biopsy
  4. Electromyography
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Research Institutes
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends